Multiple myeloma remission following COVID-19: an observation in search of a mechanism (a case report)

Coronavirus disease 2019 (COVID-19) represents a major challenge in the management of patients with hematologic malignancies. Individuals with plasma cell dyscrasias, including multiple myeloma, are at increased risk of developing severe disease. Furthermore, immunosuppressant agents, which represen...

Descripción completa

Detalles Bibliográficos
Autores principales: Antwi-Amoabeng, Daniel, Ulanja, Mark Bilinyi, Beutler, Bryce David, Reddy, Suresh Vodur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The African Field Epidemiology Network 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396390/
https://www.ncbi.nlm.nih.gov/pubmed/34512853
http://dx.doi.org/10.11604/pamj.2021.39.117.30000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396390/
https://www.ncbi.nlm.nih.gov/pubmed/34512853
http://dx.doi.org/10.11604/pamj.2021.39.117.30000

Ejemplares similares